← Leaderboards
Vladislav Sviderskiy
New York University School Of Medicine
$150,060
Attributed
$150,060
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $50.5K · FY2018–20$100K$75K$50K$25K$0
'18
'19
'20
Funding mix
By agency
NIH$150,060 · 1
By mechanism
F30$150,060 · 1
Top collaborators
No co-investigators on record.
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Robert Schneider$25,547,299
- Anne Zeleniuch-Jacquotte$14,853,206
- Chuanshu Huang$11,325,976
- Eva Hernando$15,270,218
- Iannis Aifantis$31,581,069
Others in their field
Other Emerging Leaders on “Anabolism”
- Terry Roemer · Prokaryotics, Inc.$13,565,894
- Robert Nicol · Broad Institute, Inc.$7,498,771
- Zhao Wang · Ut Southwestern Medical Center$5,368,275
- Costas Andreas Lyssiotis · University Of Michigan At Ann Arbor$4,982,483
- Yousong Ding · University Of Florida$4,468,134
- Andrew T Ulijasz · Loyola University Chicago$3,784,401
Research focus
AnabolismDna DamageAnticancer TreatmentAreaAutomobile DrivingBaseBreast Cancer Cell LineBreast Cancer MetastasisBreast Cancer PreventionBreast Cancer TreatmentCancer BiologyCancer SubtypesCell LineCell PhysiologyCellsCessation Of LifeCofactorCysteineCytotoxic ChemotherapyDefectDesignDiagnosisDna BiosynthesisDna-Directed Dna Polymerase
Grant awards (3)
Targeting Iron-Sulfur Cluster Biosynthesis for the Treatment of Basal-Like Breast Cancer$50,520
F30 · FY2020 · CA · contact PI
Targeting Iron-Sulfur Cluster Biosynthesis for the Treatment of Basal-Like Breast Cancer$50,016
F30 · FY2019 · CA · contact PI
Targeting Iron-Sulfur Cluster Biosynthesis for the Treatment of Basal-Like Breast Cancer$49,524
F30 · FY2018 · CA · contact PI